# Linda S. Harper, M.D., Orlando, FL – FDA Inspections

Source: https://www.keypedia.com/companies/linda-s-harper-md/5bf23cfd-4270-4cb7-b45a-024cdd7bef5e

> Inspection records and compliance data for Linda S. Harper, M.D. in Orlando, Florida. 8 FDA inspections on record, last inspected May 17, 2021.

---

## Details

- Name: Linda S. Harper, M.D.
- FEI Number: 3003863671
- Address Line 1: 618 E South St Ste 100
- City: Orlando
- State: Florida
- Zip Code: 32801
- Country Name: United States
- Address: 618 E South St Ste 100, Orlando, Florida 32801, United States
- Country: United States

## Related Documents

- FDA Inspection 1142609 - Linda S. Harper, M.D. - 2021-05-17 — classification: No Action Indicated (NAI), source: FDA, date: May 17, 2021
- FDA Inspection 1142609 - Linda S. Harper, M.D. - 2021-05-17 — classification: No Action Indicated (NAI), source: FDA, date: May 17, 2021
- FDA Inspection 1098448 - Linda S. Harper, M.D. - 2019-07-16 — classification: No Action Indicated (NAI), source: FDA, date: July 16, 2019
- FDA Inspection 895131 - Linda S. Harper, M.D. - 2014-09-05 — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2014
- FDA Inspection 880724 - Linda S. Harper, M.D. - 2014-06-02 — classification: No Action Indicated (NAI), source: FDA, date: June 2, 2014
- FDA Inspection 874418 - Linda S. Harper, M.D. - 2014-04-14 — classification: No Action Indicated (NAI), source: FDA, date: April 14, 2014
- FDA Inspection 793961 - Linda S. Harper, M.D. - 2012-08-20 — classification: No Action Indicated (NAI), source: FDA, date: August 20, 2012
- FDA Inspection 658418 - Linda S. Harper, M.D. - 2010-06-28 — classification: No Action Indicated (NAI), source: FDA, date: June 28, 2010
- FDA Inspection 544330 - Linda S. Harper, M.D. - 2008-10-08 — classification: No Action Indicated (NAI), source: FDA, date: October 8, 2008

## Related Companies

- [Toxin Technology, Inc.](https://www.keypedia.com/companies/toxin-technology-inc/b690e1ce-5ae7-4253-b500-b3c9a62d906e)
- [Century Clinical Research Inc](https://www.keypedia.com/companies/century-clinical-research-inc/bbcc1014-1ca1-4e29-a49d-44b484593053)
- [Dolores (n.m.i.) Sanchez-Cazau , MD](https://www.keypedia.com/companies/dolores-nmi-sanchez-cazau-md/a106c224-955b-4c38-b173-26e10b9fd49e)
- [Jeffrey A. Norton, MD](https://www.keypedia.com/companies/jeffrey-a-norton-md/40c012f5-f6c2-47f2-b376-2db26aeb5fde)
- [Nagrani Mark, Md](https://www.keypedia.com/companies/nagrani-mark-md/e093f928-7703-47df-8108-f2481c6f03a8)
- [Salman M. Muddassir MD](https://www.keypedia.com/companies/salman-m-muddassir-md/f3248e9c-303f-46eb-9855-f513891719d2)
- [David Nelson](https://www.keypedia.com/companies/david-nelson/6ea28595-3d16-4413-acfe-7f5f95740367)
- [ADVANCED PHARMA CR](https://www.keypedia.com/companies/advanced-pharma-cr/bd10c070-c861-4a71-abe8-467d0bd5b5d2)
- [Merck Sharp & Dohme Corp.](https://www.keypedia.com/companies/merck-sharp-dohme-corp/88605cae-a0a6-4c01-aa52-aae9da6cdfb9)
- [Godson I. Oguchi, M.D.](https://www.keypedia.com/companies/godson-i-oguchi-md/305ec03e-9346-4000-b305-e6d7c8bd123a)